2024 annual financial data
X4 Pharmaceuticals 2024 Net margin
Direct answer
Net margin was -1,464.61%.
Operating income was -36,401,000 USD and net income was -37,450,000 USD.
Operating cash flow was -130,901,000 USD.
Get free X4 Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,557,000 USD
- Operating income
- -36,401,000 USD
- Net income
- -37,450,000 USD
- Operating cash flow
- -130,901,000 USD